These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29914349)

  • 41. Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
    Haas-Lude K; Heimgärtner M; Winter S; Mautner VF; Krägeloh-Mann I; Lidzba K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):164-169. PubMed ID: 29111114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discrepancies between self- and adult-perceptions of social competence in children with neuropsychiatric disorders.
    Vuori M; Autti-Rämö I; Junttila N; Vauras M; Tuulio-Henriksson A
    Child Care Health Dev; 2017 Sep; 43(5):670-678. PubMed ID: 27644170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1.
    Maier A; Pride NA; Hearps SJC; Shah N; Porter M; North KN; Payne JM
    Child Neuropsychol; 2024 Feb; 30(2):348-359. PubMed ID: 37038321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Praxis skills and executive function in children with neurofibromatosis type 1.
    Remigereau C; Roy A; Costini O; Barbarot S; Bru M; Le Gall D
    Appl Neuropsychol Child; 2018; 7(3):224-234. PubMed ID: 28296469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Theory of mind in children with Neurofibromatosis Type 1.
    Payne JM; Porter M; Pride NA; North KN
    Neuropsychology; 2016 May; 30(4):439-48. PubMed ID: 26752121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se.
    Lion-François L; Herbillon V; Peyric E; Mercier C; Gérard D; Ginhoux T; Coutinho V; Kemlin I; Kassai B; Desportes V; Michael GA
    J Atten Disord; 2020 Nov; 24(13):1807-1823. PubMed ID: 28587546
    [No Abstract]   [Full Text] [Related]  

  • 47. Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
    Payne JM; Haebich KM; MacKenzie R; Walsh KS; Hearps SJC; Coghill D; Barton B; Pride NA; Ullrich NJ; Tonsgard JH; Viskochil D; Schorry EK; Klesse L; Fisher MJ; Gutmann DH; Rosser T; Packer RJ; Korf B; Acosta MT; Bellgrove MA; North KN
    J Atten Disord; 2021 Jun; 25(8):1177-1186. PubMed ID: 31838937
    [No Abstract]   [Full Text] [Related]  

  • 48. RASopathies are associated with a distinct personality profile.
    Bizaoui V; Gage J; Brar R; Rauen KA; Weiss LA
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jun; 177(4):434-446. PubMed ID: 29659143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychopathological features in Noonan syndrome.
    Perrino F; Licchelli S; Serra G; Piccini G; Caciolo C; Pasqualetti P; Cirillo F; Leoni C; Digilio MC; Zampino G; Tartaglia M; Alfieri P; Vicari S
    Eur J Paediatr Neurol; 2018 Jan; 22(1):170-177. PubMed ID: 29037749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.
    Domon-Archambault V; Gagnon L; Benoît A; Perreault S
    J Child Neurol; 2018 Mar; 33(3):225-232. PubMed ID: 29318935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Children and adolescents with neurofibromatosis 1: a behavioral phenotype.
    Dilts CV; Carey JC; Kircher JC; Hoffman RO; Creel D; Ward K; Clark E; Leonard CO
    J Dev Behav Pediatr; 1996 Aug; 17(4):229-39. PubMed ID: 8856518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive and psychosocial phenotype of young children with neurofibromatosis-1.
    Klein-Tasman BP; Janke KM; Luo W; Casnar CL; Hunter SJ; Tonsgard J; Trapane P; van der Fluit F; Kais LA
    J Int Neuropsychol Soc; 2014 Jan; 20(1):88-98. PubMed ID: 24229851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
    Colley A; Donnai D; Evans DG
    Clin Genet; 1996 Feb; 49(2):59-64. PubMed ID: 8740913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family.
    Pasmant E; Amiel J; Rodriguez D; Vidaud M; Vidaud D; Parfait B
    Am J Med Genet A; 2012 Sep; 158A(9):2290-1. PubMed ID: 22847776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway.
    Garg S; Brooks A; Burns A; Burkitt-Wright E; Kerr B; Huson S; Emsley R; Green J
    Dev Med Child Neurol; 2017 May; 59(5):544-549. PubMed ID: 28160302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2014 Jun; 35(6):1310-6. PubMed ID: 24691356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple spinal nerve enlargement and SOS1 mutation: Further evidence of overlap between neurofibromatosis type 1 and Noonan phenotype.
    Santoro C; Giugliano T; Melone MAB; Cirillo M; Schettino C; Bernardo P; Cirillo G; Perrotta S; Piluso G
    Clin Genet; 2018 Jan; 93(1):138-143. PubMed ID: 28456002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention to faces in social context in children with neurofibromatosis type 1.
    Lewis AK; Porter MA; Williams TA; Bzishvili S; North KN; Payne JM
    Dev Med Child Neurol; 2019 Feb; 61(2):174-180. PubMed ID: 29873078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Josman N
    Neuropsychol Rehabil; 2014; 24(6):918-35. PubMed ID: 24875728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.